tiprankstipranks
Trending News
More News >
Carlsmed, Inc. (CARL)
NASDAQ:CARL
US Market

Carlsmed, Inc. (CARL) Financial Statements

Compare
50 Followers

Carlsmed, Inc. Financial Overview

Carlsmed, Inc.'s market cap is currently $353.13M. The company's EPS TTM is $-0.32; its P/E ratio is -5.81; Carlsmed, Inc. is scheduled to report earnings on February 25, 2026, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23
Income Statement
Total Revenue$ 50.51M$ 27.16M$ 13.78M
Gross Profit$ 38.04M$ 20.05M$ 9.90M
Operating Income$ -30.57M$ -24.12M$ -18.59M
EBITDA$ -28.51M$ -22.79M$ -18.12M
Net Income$ -30.22M$ -24.26M$ -18.90M
Balance Sheet
Cash & Short-Term Investments$ 109.79M$ 40.13M$ 7.22M
Total Assets$ 130.12M$ 51.82M$ 14.02M
Total Debt$ 17.41M$ 17.18M$ 11.39M
Net Debt$ -68.38M$ -22.95M$ 4.17M
Total Liabilities$ 31.25M$ 122.45M$ 60.15M
Stockholders' Equity$ 98.87M$ -70.63M$ -46.13M
Cash Flow
Free Cash Flow$ -29.62M$ -25.65M$ -17.61M
Operating Cash Flow$ -28.98M$ -25.47M$ -17.48M
Investing Cash Flow$ -25.48M$ -180.00K$ -135.00K
Financing Cash Flow$ 100.13M$ 58.50M$ 3.18M
Currency in USD

Carlsmed, Inc. Earnings and Revenue History

Carlsmed, Inc. Debt to Assets

Carlsmed, Inc. Cash Flow

Carlsmed, Inc. Forecast EPS vs Actual EPS